Diagnostic microbiology and infectious disease最新文献

筛选
英文 中文
Retraction notice to "Rabies presenting as acute psychiatric behavioral abnormality with delayed onset after dog bite: A fatal case report" [Diagnostic Microbiology & Infectious Disease 113 (2025) 116881]. 《狂犬病表现为犬咬伤后迟发性急性精神行为异常1例致死性报告》[诊断微生物学与传染病113(2025)116881]。
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2027-01-01 Epub Date: 2026-09-08 DOI: 10.1016/j.diagmicrobio.2026.117627
Lan Mou, Hong Wang, Jianhua Li, Shikai Wang
{"title":"Retraction notice to \"Rabies presenting as acute psychiatric behavioral abnormality with delayed onset after dog bite: A fatal case report\" [Diagnostic Microbiology & Infectious Disease 113 (2025) 116881].","authors":"Lan Mou, Hong Wang, Jianhua Li, Shikai Wang","doi":"10.1016/j.diagmicrobio.2026.117627","DOIUrl":"10.1016/j.diagmicrobio.2026.117627","url":null,"abstract":"","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":" ","pages":"117627"},"PeriodicalIF":1.8,"publicationDate":"2027-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148911233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Development of a multiplex real-time RT-PCR assay for simultaneous detection and differentiation of influenza A, B, C, and D viruses" [Diagnostic Microbiology and Infectious Disease 95 (2019) 59-66]. “同时检测和区分甲型、乙型、丙型和丁型流感病毒的多重实时RT-PCR方法的开发”[诊断微生物学与传染病95(2019)59-66]的勘误。
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2027-01-01 Epub Date: 2026-09-03 DOI: 10.1016/j.diagmicrobio.2026.117622
Hewei Zhang, Yin Wang, Elizabeth Porter, Nanyan Lu, Yanhua Li, Fangfeng Yuan, Molly Lohman, Lance Noll, Wanglong Zheng, Colin Stoy, Yuekun Lang, Victor C Huber, Wenjun Ma, Lalitha Peddireddi, Ying Fang, Jishu Shi, Gary Anderson, Xuming Liu, Jianfa Bai
{"title":"Corrigendum to \"Development of a multiplex real-time RT-PCR assay for simultaneous detection and differentiation of influenza A, B, C, and D viruses\" [Diagnostic Microbiology and Infectious Disease 95 (2019) 59-66].","authors":"Hewei Zhang, Yin Wang, Elizabeth Porter, Nanyan Lu, Yanhua Li, Fangfeng Yuan, Molly Lohman, Lance Noll, Wanglong Zheng, Colin Stoy, Yuekun Lang, Victor C Huber, Wenjun Ma, Lalitha Peddireddi, Ying Fang, Jishu Shi, Gary Anderson, Xuming Liu, Jianfa Bai","doi":"10.1016/j.diagmicrobio.2026.117622","DOIUrl":"10.1016/j.diagmicrobio.2026.117622","url":null,"abstract":"","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":" ","pages":"117622"},"PeriodicalIF":1.8,"publicationDate":"2027-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148886721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Kernel density-encoded MALDI-TOF spectra with LightGBM machine learning for multiplex resistance prediction in Klebsiella pneumoniae" [Diagnostic Microbiology & Infectious Disease 116 (2026) 117581]. “核密度编码MALDI-TOF光谱与LightGBM机器学习用于肺炎克雷伯菌多重耐药预测”的勘误表[诊断微生物学与传染病116(2026)117581]。
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2027-01-01 Epub Date: 2026-09-26 DOI: 10.1016/j.diagmicrobio.2026.117666
Keqing Zhang, Heng Shen, Yanyan Hu, Zelin Yan, Linping Zhang, Rong Zhang
{"title":"Corrigendum to \"Kernel density-encoded MALDI-TOF spectra with LightGBM machine learning for multiplex resistance prediction in Klebsiella pneumoniae\" [Diagnostic Microbiology & Infectious Disease 116 (2026) 117581].","authors":"Keqing Zhang, Heng Shen, Yanyan Hu, Zelin Yan, Linping Zhang, Rong Zhang","doi":"10.1016/j.diagmicrobio.2026.117666","DOIUrl":"10.1016/j.diagmicrobio.2026.117666","url":null,"abstract":"","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":" ","pages":"117666"},"PeriodicalIF":1.8,"publicationDate":"2027-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149059324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis C care cascade in a university hospital: Gaps in HCV RNA testing and treatment initiation. 大学医院的丙型肝炎护理级联:HCV RNA检测和治疗启动的差距
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2026-11-11 DOI: 10.1016/j.diagmicrobio.2026.117749
Güliz Uyar Güleç, Sevin Kırdar
{"title":"Hepatitis C care cascade in a university hospital: Gaps in HCV RNA testing and treatment initiation.","authors":"Güliz Uyar Güleç, Sevin Kırdar","doi":"10.1016/j.diagmicrobio.2026.117749","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117749","url":null,"abstract":"<p><strong>Background: </strong>Evaluation of the hepatitis C virus (HCV) care cascade using real-world data helps identify gaps in HCV elimination strategies. This study assessed the HCV care cascade in a tertiary-care university hospital in Türkiye and investigated factors associated with confirmatory HCV RNA testing.</p><p><strong>Methods: </strong>All individuals who underwent anti-HCV testing between 2017 and 2020 were retrospectively evaluated, without age restrictions. The cascade stages included anti-HCV positivity, confirmatory HCV RNA testing, antiviral treatment initiation, and post-treatment virological assessment. Multivariable logistic regression was used to identify factors associated with confirmatory HCV RNA testing.</p><p><strong>Results: </strong>Among 95,836 individuals tested, 690 (0.72%) were anti-HCV positive. Confirmatory HCV RNA testing was performed in 505 (73.2%), of whom 151 (29.9%) had detectable HCV RNA. Treatment was initiated in 96 (63.6%) of the 151 viremic patients. Post-treatment HCV RNA results were available for 78 of the 96 treated patients; 18 had no documented post-treatment assessment. In multivariable analysis, evaluation in internal medicine departments (adjusted odds ratio [aOR], 5.62; 95% CI, 3.77-8.37; P < 0.001) and higher anti-HCV signal-to-cutoff levels (aOR, 1.08; 95% CI, 1.04-1.13; P < 0.001) were independently associated with confirmatory testing.</p><p><strong>Conclusion: </strong>Confirmatory HCV RNA testing was the major point of attrition in the care cascade, with substantial differences between internal medicine and surgical departments. Additional gaps occurred in treatment initiation and post-treatment assessment. Reflex testing and electronic alerts may warrant evaluation as potential strategies to improve continuity of care.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117749"},"PeriodicalIF":1.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic utility of lipoarabinomannan antigen detection in urine for the diagnosis of spinal tuberculosis in HIV negative population. 尿中脂arabinman聚糖抗原检测对HIV阴性人群脊柱结核的诊断价值。
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2026-11-11 DOI: 10.1016/j.diagmicrobio.2026.117750
Aranya Kumar Das, Kiran Bala, Manish Soneja, Deepti Vibha, Vivek Shankar, Prayas Sethi, Maroof Ahmad Khan, Urvashi B Singh
{"title":"Diagnostic utility of lipoarabinomannan antigen detection in urine for the diagnosis of spinal tuberculosis in HIV negative population.","authors":"Aranya Kumar Das, Kiran Bala, Manish Soneja, Deepti Vibha, Vivek Shankar, Prayas Sethi, Maroof Ahmad Khan, Urvashi B Singh","doi":"10.1016/j.diagmicrobio.2026.117750","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117750","url":null,"abstract":"<p><strong>Background: </strong>Microbiological confirmation of spinal tuberculosis (TB) is challenging because of paucibacillary nature and difficulty obtaining tissue samples. Evidence regarding urinary lipoarabinomannan (LAM) in spinal TB, among HIV-negative patients, is limited. We evaluated its diagnostic performance in spinal TB.</p><p><strong>Methods: </strong>We conducted a prospective observational diagnostic accuracy study at a tertiary-care centre in New Delhi, India, between September 2024 and June 2026. Adults (>18 years) with suspicion of spinal TB who were antitubercular treatment-naïve or had treatment for <2 weeks were enrolled. Urinary LAM testing was performed using Abbott Determine™ TB LAM assay. Diagnostic performance was assessed against microbiological and composite reference standards.</p><p><strong>Results: </strong>We enrolled 139 participants, including 71 (51.1%) with isolated Pott's spine and 68 (48.9%) with disseminated TB involving spine. Microbiological sampling was possible in 122 (87.8%), with 89 (64.0%) confirmed TB cases. Urinary LAM was positive in 44/139 (31.7%). Against disease status defined as concordant microbiological and composite reference standards, urinary LAM showed 92.3% specificity and 37.3% sensitivity, with a PPV of 95.7% and NPV of 24.5%. Specificity and PPV were 100% in isolated Pott's spine and 87.5% in disseminated TB involving spine. Against MGIT, sensitivity was 34.2% and specificity 69.6%. Combining urinary LAM with GeneXpert increased sensitivity to 100% against MGIT.</p><p><strong>Conclusion: </strong>Urinary LAM demonstrated high specificity, good rule-in potential in HIV-negative spinal tuberculosis. A positive result provides useful supportive evidence, particularly when microbiological confirmation is difficult. As a non-invasive test, it may complement GeneXpert as an adjunctive diagnostic tool, especially in resource-limited settings.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117750"},"PeriodicalIF":1.8,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combinatorial effect of STK11 with rifampicin prevents the growth of Mycobacterium tuberculosis bacilli more effectively through the M2 to M1 repolarization in J774A.1 macrophage. STK11与利福平联合作用,通过J774A.1巨噬细胞的M2 - M1复极化更有效地抑制结核分枝杆菌的生长。
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2026-11-10 DOI: 10.1016/j.diagmicrobio.2026.117748
Arijeet Samanta, Madhusri Pramanik, Nayanika Datta, Sajal Dasmahapatra, Santanu Kar Mahapatra
{"title":"Combinatorial effect of STK11 with rifampicin prevents the growth of Mycobacterium tuberculosis bacilli more effectively through the M2 to M1 repolarization in J774A.1 macrophage.","authors":"Arijeet Samanta, Madhusri Pramanik, Nayanika Datta, Sajal Dasmahapatra, Santanu Kar Mahapatra","doi":"10.1016/j.diagmicrobio.2026.117748","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117748","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis remains a major global health challenge, disproportionately affecting developing countries-most notably in India, which accounts for the largest number of cases worldwide. This study aimed to explore the efficacy of Cocos nucifera L. derived glycoprotein STK11 in combination with rifampicin to investigate the significance of host-directed therapy against Mycobacterium tuberculosis infected macrophages.</p><p><strong>Methods: </strong>The therapeutic worth of the STK11 and rifampicin in combination was evaluated against M. tuberculosis H37Ra bacilli using a resazurin microplate assay to measure extracellular growth. Additionally, an intracellular survival assay was performed to determine bacillary restriction within infected macrophages. Macrophage polarization profiles (M1 vs. M2 markers) were evaluated via RT-PCR and ELISA, and arginase activity was monitored to assess functional biochemical shifts.</p><p><strong>Results: </strong>The combination of STK11 and rifampicin restricted H37Ra bacilli growth by up to 63.19% more effectively than individual treatments. Furthermore, this combination restricted intracellular bacillary growth within macrophages by up to 72.20% compared to single-drug treatments. During baseline H37Ra macrophage infection, RT-PCR revealed an upregulation of M2 markers (Arg1, YM-1, FIZZ1, CD206, IL-4, IL-10) and a downregulation of M1 markers (iNOS2, CD40, CD68, IL-6, IL-12). However, combination therapy with STK11 and rifampicin significantly (p<0.05) decreased arginase activity and restored M1 marker expression. These results demonstrated the shift of M2 macrophage polarization to M1 phenotype which might crucial for restricting M. tuberculosis growth.</p><p><strong>Conclusions: </strong>Altogether, this study claimed that the C. nucifera L. derived glycoprotein STK11 provided a viable host-directed combination therapy with rifampicin to enhance clearance and effective suppression of M. tuberculosis H37Ra growth.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117748"},"PeriodicalIF":1.8,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective analysis of human adenovirus infection prevalence in children with respiratory tract infections following the COVID-19 pandemic in Shaoxing. 绍兴市2019冠状病毒病大流行后呼吸道感染儿童人腺病毒感染流行情况回顾性分析
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2026-11-09 DOI: 10.1016/j.diagmicrobio.2026.117747
Jianwei Zhang, Jinlong Ding, Xinqi Ma
{"title":"Retrospective analysis of human adenovirus infection prevalence in children with respiratory tract infections following the COVID-19 pandemic in Shaoxing.","authors":"Jianwei Zhang, Jinlong Ding, Xinqi Ma","doi":"10.1016/j.diagmicrobio.2026.117747","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117747","url":null,"abstract":"<p><strong>Objective: </strong>Human adenovirus (HAdV) activity has changed across Chinese regions during the transition from COVID-19 containment to subsequent years. We examined whether HAdV positivity among children hospitalized with acute respiratory infections (ARIs) in Shaoxing increased from 2022 to 2024 and described its distribution by age, season, and clinical presentation.</p><p><strong>Methods: </strong>This single-center retrospective study included 9,714 hospitalized children aged <14 years with ARIs from January 2022 through December 2024. Respiratory specimens were tested for HAdV DNA using fluorescent probe-based polymerase chain reaction (PCR). Positivity was calculated among tested children, and clinical findings were summarized among HAdV-positive patients.</p><p><strong>Results: </strong>HAdV was detected in 461 children (4.75%). Reported annual positivity increased from 0.85% in 2022 to 2.07% in 2023 and 8.99% in 2024. Based on the tabulated counts, positivity was 1.15%, 5.03%, 7.42%, and 7.74% in children aged <1, 1-<3, 3-<5, and ≥5 years, respectively. Summer had the highest pooled seasonal positivity (190/2,275; 8.35%). Positivity was 5.10% in lower ARIs and 3.60% in upper ARIs. Among HAdV-positive children, fever occurred in 415 (90.02%), cough in 370 (80.26%), and lower ARIs in 378 (82.00%).</p><p><strong>Conclusions: </strong>HAdV positivity increased among tested pediatric inpatients in Shaoxing from 2022 to 2024, with higher pooled positivity in older age groups and summer. These findings support continued hospital surveillance, including molecular typing to investigate circulating types.</p><p><strong>Importance: </strong>The transmission route of HAdV is similar to that of COVID-19, suggesting that the effect of non-drug intervention on the two may be equivalent. The purpose of this study was to analyze the epidemiological characteristics of HAdV infection in children in Shaoxing from 2022 to 2024. This study explored the impact of COVID-19 and non-drug interventions on the prevalence of HAdV, and provided guidance for disease treatment and infection prevention.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117747"},"PeriodicalIF":1.8,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of MALDI-TOF MS and VITEK 2 performance in the identification of brucella strains isolated from blood culture bottles; retrospective evaluation of antibiotic resistance profiles, clinical manifestations, and serological follow-up. MALDI-TOF MS与VITEK 2鉴定血培养瓶布氏菌的性能比较抗生素耐药情况、临床表现及血清学随访的回顾性评价。
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2026-11-07 DOI: 10.1016/j.diagmicrobio.2026.117744
Merve Ertürk Melez, Pınar Sağıroğlu, Sıtkı Özgür Altop, Mustafa Altay Atalay, Orhan Yıldız
{"title":"Comparison of MALDI-TOF MS and VITEK 2 performance in the identification of brucella strains isolated from blood culture bottles; retrospective evaluation of antibiotic resistance profiles, clinical manifestations, and serological follow-up.","authors":"Merve Ertürk Melez, Pınar Sağıroğlu, Sıtkı Özgür Altop, Mustafa Altay Atalay, Orhan Yıldız","doi":"10.1016/j.diagmicrobio.2026.117744","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117744","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Brucella species cause severe zoonotic infections with an exceptionally high risk of laboratory-acquired transmission. We systematically evaluated and compared the identification performances of two contemporary MALDI-TOF MS platforms and the VITEK 2 automated system, analyzed serial standard tube agglutination (STA) titer kinetics, and determined in vitro antimicrobial susceptibility profiles of clinical blood culture isolates.</p><p><strong>Materials and methods: </strong>Twenty-five culture-confirmed Brucella isolates recovered from peripheral blood culture bottles between 2019 and 2025 were evaluated using the MALDI Biotyper Sirius (routine MBT Compass library), VITEK MS Prime (IVD database v3.3), and VITEK 2 GN automated identification cards. All sample manipulation and ethanol/formic acid extraction were performed inside a certified Class II Biosafety Cabinet ensuring complete inactivation prior to mass spectrometry. Antimicrobial susceptibility was determined by the disk diffusion method on Mueller-Hinton Fastidious (MH-F) agar according to EUCAST (v. 16.0) guidelines. Clinical data and serial STA titers were retrospectively analyzed.</p><p><strong>Results: </strong>The MALDI Biotyper Sirius accurately identified all 25 isolates (100%) at the species level as Brucella melitensis, whereas the VITEK MS Prime identified all (100%) at the genus level (Brucella spp.). In contrast, the VITEK 2 GN automated system demonstrated markedly poor diagnostic utility, correctly identifying 92% (23/25) of isolates, failing to identify one isolate ('unidentified'), and misidentifying another blood culture isolate as Roseomonas gilardii. A statistically significant decrease in Wright tube agglutination titers was observed following treatment (median initial titer 1:320 [IQR, 1:160-1:640] vs. median final titer 1:80 [IQR, 1:40-1:160]; p = 0.007). Serological reductions did not differ significantly across therapeutic regimens (p = 0.3219). All isolates (100%) were fully susceptible to rifampin, doxycycline and gentamicin. Resistance rates to trimethoprim-sulfamethoxazole (SXT) and ciprofloxacin were 40% (10/25) and 24% (6/25), respectively. Favorable clinical cure without relapse was achieved in patients receiving SXT-containing regimens despite in vitro resistance.</p><p><strong>Conclusions: </strong>The MALDI Biotyper Sirius provides superior diagnostic speed and biosafety via reliable species-level identification using routine spectral libraries. Automated phenotypic misidentifications (e.g., R. gilardii) represent critical biohazards that warrant urgent MALDI-TOF MS verification. High in vitro resistance to SXT highlights potential disk diffusion overestimation in fastidious organisms, emphasizing the necessity of broth microdilution MIC confirmation before precluding vital oral treatment options.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117744"},"PeriodicalIF":1.8,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic significance of low-level Mycobacterium tuberculosis detection by the BD MAX MDR-TB assay: A retrospective descriptive study. bdmax耐多药结核试验检测低水平结核分枝杆菌的诊断意义:一项回顾性描述性研究。
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2026-11-06 DOI: 10.1016/j.diagmicrobio.2026.117740
Oğuz Alp Gürbüz, Zübeyde Lale, Nesibe Nur Aydın
{"title":"Diagnostic significance of low-level Mycobacterium tuberculosis detection by the BD MAX MDR-TB assay: A retrospective descriptive study.","authors":"Oğuz Alp Gürbüz, Zübeyde Lale, Nesibe Nur Aydın","doi":"10.1016/j.diagmicrobio.2026.117740","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117740","url":null,"abstract":"<p><strong>Background: </strong>Nucleic acid amplification tests (NAATs) are crucial for the quick diagnosis of tuberculosis (TB). Low-positive BD MAX MDR-TB PCR results continue to be diagnostically difficult, and clinical outcomes for this patient group have not been thoroughly characterised.</p><p><strong>Objective: </strong>To evaluate the clinical significance of low-positive BD MAX MDR-TB PCR results and determine the proportion of patients subsequently diagnosed with TB or with a prior TB history.</p><p><strong>Methods: </strong>This retrospective descriptive study included patients tested with BD MAX MDR-TB PCR between January 2023 and December 2025. Among 16,134 tested samples, 70 patients with low-positive results were identified. Concurrent microbiological data, including acid-fast bacilli smear microscopy, MGIT culture, Löwenstein-Jensen culture, and antibiogram results when available, were reviewed.</p><p><strong>Results: </strong>Persistent low-positivity was observed in 47 (67.1%) of 70 patients on repeat testing, of whom 28 (59.6%) were diagnosed with TB or had prior TB treatment. The remaining 23 patients (32.9%) converted to negative on repeat testing; all had negative smear and culture results, and no active TB diagnosis was established.</p><p><strong>Conclusions: </strong>Low-positive results provides an early molecular signal that can trigger timely clinical assessment, infection-control measures, and targeted microbiological follow-up before definitive culture results become available but when clinical suspicion is low and subsequent AFB smear and culture results are negative, a low-positive molecular result should be interpreted cautiously and should not, by itself, establish a diagnosis of active TB.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117740"},"PeriodicalIF":1.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genus-wide PCR and 23S-5S ISR sequencing reveals diverse non-pneumophila Legionella in clinical respiratory samples. 全属PCR和23S-5S ISR测序显示临床呼吸样本中存在多种非嗜肺军团菌。
IF 1.8 4区 医学
Diagnostic microbiology and infectious disease Pub Date : 2026-11-06 DOI: 10.1016/j.diagmicrobio.2026.117738
Jonas Steenholdt Sparvath, Randi Føns Petersen, Jørgen Skov Jensen, Charlotte Kjelsø, Søren Anker Uldum
{"title":"Genus-wide PCR and 23S-5S ISR sequencing reveals diverse non-pneumophila Legionella in clinical respiratory samples.","authors":"Jonas Steenholdt Sparvath, Randi Føns Petersen, Jørgen Skov Jensen, Charlotte Kjelsø, Søren Anker Uldum","doi":"10.1016/j.diagmicrobio.2026.117738","DOIUrl":"https://doi.org/10.1016/j.diagmicrobio.2026.117738","url":null,"abstract":"<p><strong>Objectives: </strong>To determine how the breadth of the molecular diagnostic target shapes detection of Legionella in clinical respiratory samples, and to characterise the species diversity of non-pneumophila Legionella (non-Lp) using 23S-5S rRNA intergenic spacer region (ISR) sequencing.</p><p><strong>Methods: </strong>Respiratory samples reported Legionella PCR-positive by Danish laboratories during 2023-2024 were reconfirmed at the national reference laboratory by real-time PCR targeting 16S rRNA (genus), mip (L. pneumophila) and wzm (serogroup 1). Samples positive for 16S rRNA but negative for mip underwent 23S-5S ISR sequencing with phylogenetic and UPGMA-based species assignment. Detection patterns were compared between hospitals using genus-wide versus L. pneumophila-specific assays. Culture confirmation was modelled against Ct value by species and specimen type.</p><p><strong>Results: </strong>Among 509 PCR-positive patients, genus-level 16S rRNA testing reconfirmed Legionella in clinically indicated samples that L. pneumophila-specific assays would have reported negative. Of 96 high-quality ISR sequences, non-Lp detections were distributed broadly across the Legionella phylogeny, including L. longbeachae, L. bozemanae, L. anisa, several rare species and unassigned clusters. A subset of mip-negative samples was genuinely L. pneumophila, showing that even same-species narrow detection can fail. Culture confirmation was higher for L. pneumophila (50%) than for non-Lp species (0-47%). Among 420 notified Legionnaires' disease cases, 85 (20.2%) were non-Lp.</p><p><strong>Conclusions: </strong>A negative L. pneumophila PCR does not exclude legionellosis. Genus-wide molecular detection recovers confirmed infections missed by narrow assays, and the wide phylogenetic spread of organisms means a broad approach, not a small species-specific add-on, is required for adequate diagnosis and surveillance.</p>","PeriodicalId":11329,"journal":{"name":"Diagnostic microbiology and infectious disease","volume":"117 2","pages":"117738"},"PeriodicalIF":1.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书